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Introduction
Photodynamic therapy (PDT) is a treatment modality based on photoactive substances of photosensitizers that localize preferentially in tumor cells. Irradiation of the target tissues with the appropriate wavelength of light activates the production of highly reactive oxygen and leads to a series of phototoxic reactions that cause selective death of tumor cells. Remarkable advancements have been made in recent decades to improve the efficiency of three PDT basic components: light, oxygen and photosensitizers; along with increased understanding of their biomedical and biophysical function. 1 Studies have been conducted to treat a variety of malignant and premalignant cancer conditions including head and neck cancer, lung cancer, mesothelioma, Barrett's esophagus, prostate and brain tumors. 2 The main advantage of PDT lies in it being a selective cancer treatment due to enrichment of the localized photosensitizers in the tissue and the directing of light to the affected tissue. The selectivity of PDT can be increased through targeted delivery of the photosensitizers to its site of action. Thus, side-effects are minimized and the therapeutic window is widened through increasing the target/non-target tissue ratio. This can result in a reduction of the effective photosensitizer dose and its toxicity. In addition, the exact localization of a photosensitizer is important because the active singlet oxygen has a short life time of about 0.01μs with a range of action of about 0.01-0.02 μm.
3
Targeted delivery systems employing various carriers have been developed especially using hydrophobic photosensitizers. 4 Common carriers can be divided into three classes: i) soluble carrier, such as monoclonal antibodies, emulsions or polymers;
5 ii) particulate carriers of liposomes, nanoparticles or microspheres 6 and iii) the target specific recognition 7 of carbohydrates, 8 lectins, oligonucleotides, epidermal growth factors, peptides, hormones, vitamins or lipoproteins. While the targeted photosensitizers delivery are capable of attaining sitespecific delivery, a major concern is to control the release kinetics of the photosensitizers in a predictable manner and to deliver them at a pre-determined rate. One area of 
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Tetrahedron 2 interest is the development of photosensitizer release systems that can be triggered externally. 9 For example, a photochemically triggered release system can be achieved through photocleavage of specific bonds in a pro-drug molecular system. This offers more control and specificity as the light beam can be turned on and off (temporal control) and light can be focused at particular sites (spatial control).
Our approach is to link porphyrin photosensitizers to ligand molecules and subsequently attempt a photo-release of the porphyrin photosensitizers in targeted tumor tissue. The construction of photocleavable porphyrin-conjugate systems will enhance the specific targeting of photosensitizers and localize their activation at defined effector places. In addition, tumor necrosis or induced apoptosis that contribute to cell death require light activation. 10 Thus, photocleavable linkers would be most advantageous. We proposed earlier to utilize the photolabile spirobisdithianes and trithiane as such linker groups, however the strategy had its limits due to instability of the porphyrin systems towards photocleavage under ambient conditions. 11 Recently, photolabile o-nitrobenzyl linkers were utilized to design light-triggered anticancer pro-drugs which released the tegafur drug from porphyrins upon photolysis. 12 oNitrobenzyl linkers have advantages due to their compatibility with a variety of functional groups, ease of synthesis, stability under ambient light, clean cleavage and fast fragmentation upon photoirradiation. 13 In the present work, we develop the necessary synthetic methodologies for the construction of labile systems for porphyrin photosensitizers based on the o-nitrobenzyl linker group and selected bioconjugates.
Results and discussion

Synthetic rational
Although various approaches to porphyrin functionalization have been established, esterification reactions have been mainly utilized in attempts to attach porphyrin moieties to bioconjugates via linker groups. Two synthetic pathways were chosen to synthesize the target compounds: i) esterification of porphyrin-carboxylic acids with onitrobenzyl alcohol containing systems and the appropriate bioconjugate and ii) the coupling of hydroxyl porphyrins with selected bioconjugates (Scheme 1).
These approaches require the presence of bioconjugates reactive towards the phenolic functional group. The latter method is developed through employing protecting group synthons, which later can be deprotected to obtain the active porphyrin, and provides convenient visual experimental monitoring due to associated color changes of the porphyrins. Individual syntheses will be discussed for the specific target compounds. 
Starting materials-carboxylic acid porphyrins
A direct route to obtain carboxylic acid porphyrins is through hydrolysis of ester-type porphyrins. Several known methods are available. One of these is the use of palladiumcatalysed Suzuki 14 and Heck 15 coupling reactions using halogenated porphyrin precursors. Hence, the initial step involved bromination 16 at the meso-or β-position of several free base porphyrins (1-6) which were accessible through standard condensation 17 or RLi-alkylation procedures. 18 Consequently, Suzuki and Heck coupling reactions were carried out using methylester-boronic acid or -vinyl derivatives. These afforded a range of ester porphyrins in good yields (7-15) (Scheme 2).
Another method that enables the introduction of ester functional groups is to condense a mixture of pyrrole and the appropriately substituted benzaldehyde in a particular ratio. 19 This condensation reaction leads to the synthesis of a tetrasubstituted compound (16) and ester porphyrin (17) (Scheme 2). Addition of zinc acetate as a metal template during the condensation process can facilitate the reaction, thus increasing the yield of the condensed products. 20 The free base porphyrin can be obtained subsequently under acidic conditions. All of the ester porphyrins were further converted to functionalised carboxylic acids porphyrins via basehydrolysis using NaOH-EtOH 19 and afforded compounds 18-27 in high yields.
Esterification of porphyrins
The esterification of carboxylic acid porphyrins is often achieved using acylation 21 or carbodiimide coupling techniques. 22 However, the carbodiimide coupling offers a more feasible method as it requires simple and moderate conditions. We have investigated several preliminary esterification reactions between carboxylic acid porphyrins 7, 9, 28, 22c 29 22d and 2-nitrobenzylalcohol as the model linker using primarily N,N'-dicyclohexylcarbodiimide (DCC). However, the reactions tend to undergo rearrangement to form stable N-acylisourea species (30) (31) (32) (33) instead of the reactive intermediates of o-M A N U S C R I P T 
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Scheme 2. Entry to carboxylic acid porphyrins. 23 and it has been suggested that this process occurs via a four-membered transition state (Scheme 3).
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Scheme 3. Formation of N-acylisourea porphyrins.
A crystal structure of compound 30 clearly shows the Nacylisourea substitution pattern ( Figure 1 ). Meanwhile, under optimized conditions (5 eq. DCC, 1 eq. DMAP, 5 eq. nitrobenzylalcohol), we managed to obtain the respective nitrobenzyl-derivative of porphyrins (34) (35) in moderate yields (Scheme 4). To overcome the problem of low yields it is necessary to stabilize the intermediate o-acylisourea using additive of N-hydroxysuccinimide (NHS) or 1-hydroxybenzotriazole (HOBt). 24 The additive acts as the intermediate nucleophile which converts the o-acylisourea to an activated ester containing nucleophile, thus preventing the rearrangement. Further esterifications were carried out using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDAC) which has high solubility in water and organic solvents such as CH 2 Cl 2 , THF, DMF and is easy to use. These reactions proceeded efficiently and gave the target compounds (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) in high yield (Scheme 5). 
Porphyrin-linked carbohydrates
Porphyrins with carbohydrate moieties have been reported as efficient photosensitiser candidates for PDT. 25 Not only do they alter the amphiphilicity of the photosensitizers, but they also exhibit specific membrane interactions, thus resulting in specific targeting of tumor cells.
26 Therefore, a model compound of porphyrin-linker-bioconjugate was prepared by reaction of carboxylic acid porphyrin (29) with (3-hydroxymethyl-4-nitrophenyl)-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 27 to yield the target compound 44 in 76% yield (Scheme 6). 
Protecting group method
The synthesis of a nitrobenzyl analog containing an active phenolic group started with the protection of the phenolic group of 5-hydroxy-2-nitrobenzaldehyde using the acidsensitive protecting group, 2-methoxyethoxymethyl (MEM) ether, giving 45. 28 Further reduction with sodium borohydride at room temperature gave the respective nitrobenzyl alcohol 46 in quantitative yield. The esterification process with EDAC carbodiimide was employed using 18 to give 47. Deprotection of the MEM group was carried out under neutral conditions to avoid adverse reactions from the acidic conditions. Heating of 47 using ethylene glycol 29 led to the formation of 48 due to nucleophilic attack of a hydroxyl group in ethylene glycol at the reactive benzylic carbon. The resulting product was esterified with the carboxylic acid porphyrin 49 and gave the bisporphyrin 50 in 93% yield (Scheme 7). Subsequently, we decided to use trifluoroacetic acid (TFA) 30 as a deprotection reagent for cases where the porphyrin core is required to be metallated to avoid unnecessary protonation. Porphyrin 47 was metallated with zinc acetate to give 51 which after further treatment with excess TFA, the reaction progressed smoothly to eliminate the MEM-group and demetallate the porphyrin moiety yielding 52 in 81% (Scheme 8). This compound opens an entry for the attachment of diverse functional groups due to the presence of the phenolic group. However, an attempt to attach folic acid as a targeted bioconjugate 31 did not proceed as planned. Therefore, further investigation will be carried out on the optimization of their reactivity and will be reported later. 32 oNitroso benzaldehyde may further react to form secondary products via azobenzene-2,2'-dicarboxylic acid that acts as an internal filter, hence slowing the desired photoreaction.
Irradiation experiments
33
Two approaches may be used to further increase its photoefficiency: (i) introduction of an additional o-nitro group to increase hydrogen abstraction of the excited nitro group and (ii) introduction of an α-substitutent to the chromophore to enhance its efficiency for hydrogen abstraction. Both approaches require additional synthetic steps and are currently under investigation.
Conclusion
The results reported demonstrate that it is possible to synthesize compounds containing the required structural motifs for photo-cleavage. In addition, we could show the photolability of the target material. Although the deprotection is still not optimal, subsequent work will focus on improving the efficiency of the labile linker couplings and will target various bioconjugates to fulfill the potential of increased binding affinity to targeted cell receptors. Pending its success, this methodology will pave the way towards improved localization of photosensitizers in PDT and their controlled release. 13 C NMR) instrument. Chemical shifts are reported in ppm referenced to tetramethylsilane set at 0.00 ppm. High resolution mass spectrometry were measured on a Micromass/Waters Corp., USA liquid chromatography time-of-flight spectrometer equipped with an electrospray source. UV-vis measurements were performed on a Shimadzu MultiSpec-1501. Melting points were acquired on a Stuart SMP10 melting point apparatus and are uncorrected. Thin layer chromatography (TLC) was performed on silica gel 60F 254 (Merck) pre-coated aluminum sheets. Flash chromatography was carried out using Fluka Silica Gel 60 (230-400 mesh). Anhydrous THF distilled over sodium/benzophenone and dichloromethane dried over P 2 O 5 were used. All commercial chemicals were supplied by Aldrich and used without further purification.
Experimental
General Information
Bromination of porphyrins
The porphyrin was dissolved in chloroform and a few drops of pyridine were added. The solution was then cooled to 0 °C. N-Bromosuccinimide (1.1 eq) was added and the mixture was stirred (TLC monitoring) followed by evaporation of the solvent in vacuo and purification via column chromatography.
5-Bromo-15-hexyl-10,20-diphenylporphyrin (1).
A solution of 5-hexyl-10,20-diphenylporphyrin 18d (0.40 g, 0.73 mmol), pyridine (0.3 ml) and N-bromosuccinimide (0.14 g, 0.81 mmol) was dissolved in chloroform (150 ml) and stirred for 30 min. The title compound was purified by column chromatography on silica gel with nhexane/dichloromethane (2: 1, v/v) 29, 29.79, 31.44, 35.08, 38.36, 101.47, 119.76, 121.25, 126.40, 127.39, 130.48, 131.54, 141 .59 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 420 (5.21), 520 (3.90) 29.76, 30.25, 31.91, 35.52, 38.82, 55.54, 101.92, 113.63, 119.94, 120.50, 121.70, 127.53, 129.60, 143.36, 157 .95 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 421 (5.50), 520 (4.25), 554 (4.00), 598 (3.78) 
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4.2.3
2-Bromo-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)porphyrin (6). A solution of 5,10,15,20-tetrakis(3,5-di-tert-butylphenyl) porphyrin 22d (0.20 g, 0.19 mmol), pyridine (0.5 ml) and N-bromosuccinimide (0.04 g, 0.21 mmol) was dissolved in chloroform (100 ml) and stirred for 1 hour. The title compound was purified by column chromatography on silica gel with nhexane/dichloromethane (1:1, v/v) 
Synthesis of porphyrin ester
Method A: Suzuki cross coupling approach.
To a stirred slurry of K 3 PO 4 (40 eq.) in anhydrous THF were added bromoporphyrin (1 eq.), boronic acid (20 eq.), and Pd(PPh 3 ) 4 (0.2 eq.). The reaction was heated to reflux at 85 o C for 18 hours and shielded from light. The solvent was evaporated after completion and the residue was dissolved in CH 2 Cl 2 . This mixture was washed with saturated NaHCO 3 , H 2 O, and brine followed by drying over Na 2 SO 4 . The organic solvent was evaporated and the crude product was purifed by column chromatography. 34, 29.84, 31.50, 35.13, 38.49, 52.04, 117.34, 119.39, 120.83, 127.34, 127.56, 129.05, 134.20, 141.90, 146.62, 166 .99 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 419 (5.52), 517 (3.20) 20, 22.75, 30.29, 31.94, 35.60, 38.94, 52.45, 55.54, 113.55, 117.75, 119.53, 120.46, 121.28, 127.49, 127.63, 127.98, 129.48, 134.60, 143.64, 147.01, 157.93, 167.40 52.02, 65.46, 104.75, 118.54, 119.44, 126.44, 127.37, 129.14, 130.62, 134.25, 141.19, 147.02, 166.93 82, 118.51, 120.17, 126.33, 126.80, 127.49, 129.76, 134.13, 141.45, 143.88, 146.48, 166.37, 166.89 20, 22.75, 30.28, 31.93, 35.61, 38.93, 52.37, 117.77, 119.76, 121.14, 126.67, 126.93, 127.74, 128.89, 128.99, 134.52, 134.90, 138.54, 142.36, 142.47, 167 .39 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)=418 (5.14), 516 (4.08), 551 (3.93) 13.70, 22.26, 29.27, 31.39, 34.61, 51.91, 118.11, 120.68, 121.44, 126.39, 128.30, 128.56, 129.52, 134.33, 137.93, 140.50, 142.25, 148.37, 166.91 29.73, 31.94, 35.06, 52.02, 53.44, 121.01, 121.29, 122.19, 127.01, 128.55, 129.77, 130.66, 140.20, 141.42, 141.59, 148.64, 148.66, 167.15 
5-(4-
Methoxycarbonylphenyl
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Method B: Heck coupling approach.
Bromoporphyrin (1 eq.), palladium acetate (0.2 eq.) di-tertbutylbiphenylphosphine (0.5 eq.) and K 2 CO 3 (1.2 eq.) were added to a Schlenk tube and dried under vacuum. The vessel was filled with argon, followed by addition of dry DMF, dry toluene, and the vinyl reagent (50-fold excess). The mixture was then degassed via three freeze-pump-thaw cycles before the vessel was purged with argon again to ensure the reaction mixture was free of oxygen. The Schlenk flask was sealed and heated to 105 °C and the mixture was stirred for 15 hours. The progress of reaction was monitored by TLC and, upon completion, the mixture was diluted with toluene and washed with water. The organic layer was separated, dried over MgSO 4 and the residue was purified by column chromatography. (27.33 mg, 0.20 mmol) in dry DMF (10 mL) and dry toluene (10 mL), followed by heating for 15 hours (see 4.3.9) . The title compound was purifed by column chromatography on silica gel with nhexane/dichloromethane (1:2, v/v) 5-Hexyl-15-(2-methoxycarbonylethenyl)-10,20-bis(3-methoxyphenyl)porphyrin (15). Methyl acrylate (0.66 mL, 7.26 mmol) was added to a solution of 5-bromo-15-hexyl-10,20-bis(3-methoxyphenyl)porphyrin 2 (0.10 g, 0.15 mmol), palladium acetate (6.59 mg, 0.03 mmol), ditert-butylbiphenylphosphine (22.42 mg, 0.08 mmol) and K 2 CO 3 (24.85 mg, 0.18 mmol) in dry DMF (10 mL) and dry toluene (10 mL), followed by heating for 15 hours (see 4.3.9) . The mixture was purifed by column chromatography on silica gel with n-hexane/dichloromethane (1:4, v/v) 29.80, 31.45, 35.03, 38.37, 51.64, 55.09, 110.75, 113.17, 119.84, 119.98, 122.28, 129.85, 131.89, 143.04, 145.54, 157.50, 166 
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Method C: Condensation approach.
To a mixture of aldehyde (4 eq.) and Zn(OAc) 2 (1 eq.) in propionic acid, pyrrole (4 eq.) was added at 100 o C over the course of 1 hours under vigorous stirring. The resulting dark solution was heated to reflux for further a 4h and then cooled to room temperature. The solvent was evaporated and the solid residue was filtered through silica gel and all product containing fractions were collected. The volume was reduced to 100 ml and pyridine and excess DDQ were added. The resulting mixture was heated at reflux for 1 hour. The solution was cooled to room temperature and evaporated to give a black-purple crude product followed by column chromatography on silica gel. 53 mmol) and pyrrole (0.42 mL, 6.12 mmol) were reacted in propionic acid (30 mL) following method C (4.3.11). The solution volume was reduced to 100 ml and pyridine (0.5 mL) and DDQ (0.5 g) were added. The title compound was purifed by column chromatography on silica gel with n-hexane/dichloromethane 34, 34.62, 51.91, 118.69, 120.42, 122.22, 127.29, 128.71, 129.25, 130.83, 131.83, 131.98, 141.30, 147.59, 148.14, 149.03, 149.96, 150.16, 166 [5,10,15,20-tetrakis(3,5-di-tert-butylphenyl) porphyrinato]zinc(II) 16 34 (0.198 g, 0. 22 mmol, 12 %) as a red solid.
Hydrolysis of porphyrin esters
General Method.
A solution of porphyrin in THF, was mixed with ethanol and 2M NaOH and the suspension was heated to reflux (TLC monitor) before being cooled to room temperature. The mixture was acidified with aqueous HCl (1M) and extracted with chloroform. The organic extract was washed with saturated sodium bicarbonate aqueous solution and dried over anhydrous sodium sulfate. The solvent was then removed under reduced pressure before undergo further purification.
Spectroscopic data for porphyrin 21 in accordance with previous literature. 29, 27.75, 29.03, 29.75, 31.46, 34.03, 34.85, 38.29, 99.86, 118.41, 119.68, 122.80, 125.13, 126.13, 127.30, 128.41, 130.92, 134.09, 135.11, 141.02, 143.86, 148.96 29.52, 30.42, 31.90, 34.33, 38.80, 54.47, 68.08, 112.45, 118.58, 119.61, 125.62, 126.27, 126.57, 128.13, 134.69, 135.87, 142.77, 144.64, 151.62, 156.87, 176 .39 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 420 (5.27) 
5-(4-Carboxyphenyl)-10,20-diphenylporphyrin (20).
5-(4-Methoxycarbonylphenyl)-10,20-diphenylporphyrin 9 (0.15 g, 0.09 mmol) was heated to reflux in THF, ethanol (40mL) and 2M NaOH (95 ml) for 11 hours. Filtration through a plug of silica gel eluting with (CH 2 Cl 2 : EtOAc = 5:1) and evaporation of the solvent followed by recrystallization from MeOH/H 2 O gave a purple solid of 20 (0.11 g, 0.06 mmol, 77%): mp >310 o C; R f =0. 
5-(3-Carboxyphenyl)-15-hexyl-10,20-diphenyl porphyrin (22)
. 5-(3-Methoxycarbonylphenyl)-15-hexyl-10,20-diphenylporphyrin 11 (0.14 g, 0.21 mmol) was heated to reflux in THF (20 mL), ethanol (30 mL) and 2M NaOH (30 mL) for 2 hours. Filtration through a plug of silica gel eluting with (CH 2 Cl 2 : EtOAc = 5:1) followed by evaporation of the solvent gave a purple solid of 22 (0. 13 
5,15-Bis(3-carboxyphenyl)-10,20-bis(3,5-di-tertbutylphenyl)porphyrin (23).
5,15-Bis(3-methoxycarbonylphenyl)-10,20-bis(3,5-di-tert-butylphenyl) porphyrin 12 (0.02 g, 0.02 mmol) was heated to reflux in THF (10 mL), ethanol (20 mL) and 2M NaOH (20 mL) for 5 hours. Filtration through a plug of silica gel eluting with (CH 2 Cl 2 : EtOAc = 5:1) followed by evaporation of the solvent gave a purple solid of 23 (16.5 30, 32.11, 44.65, 119.20, 123.74, 124.41, 126.65, 127.58, 128.40, 129.64, 132.20, 140.66, 142.23, 149.45, 165.85 
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2-(4-Carboxyphenyl)-5,10,15,20-tetrakis(3,5-ditert-butylphenyl)porphyrin (24).
2-(4-Methoxycarbonylphenyl)-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)-porphyrin 13 (0.03 g, 0.03 mmol) was heated to reflux in THF (5 mL), ethanol (10 mL) and 2M NaOH (10 mL) for 5 hours. Filtration through a plug of silica gel eluting with CH 2 Cl 2 followed by evaporation of the solvent gave a purple solid of 24 (0.03 
5-(2-Carboxyethenyl)-15-hexyl-10,20-diphenylporphyrin (25). 5-Hexyl-15-(2-methoxycarbonylethenyl)-
10,20-diphenylporphyrin 14 (0.03 g, 0.02 mmol) was heated to reflux in THF (5 mL), ethanol (10 mL) and 2M NaOH (10 mL) for 3 hours. Filtration through a plug of silica gel eluting with (CH 2 Cl 2 : EtOAc = 5:1) followed by evaporation of the solvent gave a purple solid of 25 (0. 20, 24.19, 29.21, 29.73, 31.33, 38.28, 55.02, 94.26, 106.61, 126.31, 127.60, 127.99, 128.58, 133.66, 141.27 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 426 (5.26), 527 (3.78), 569 (3.86), 601 (3.30) 
5-(2-Carboxyethenyl)-15-hexyl-10,20-bis(3-methoxyphenyl)porphyrin (26).
5-Hexyl-15-(2-methoxycarbonylethenyl)-10,20-bis(3-methoxyphenyl)porphyrin 15 (0.06 g, 0.08 mmol) was heated to reflux in THF (5 mL), ethanol (10 mL) and 2M NaOH (10 mL) for 3 hours. Filtration through a plug of silica gel eluting with (CH 2 Cl 2 : EtOAc = 5:1) followed by evaporation of the solvent gave a purple solid of 26 (0.05 g, 0.03 mmol, 88%): mp =197 21.25, 22.72, 25.63, 29.47, 31.80, 34.28, 38.67, 54.39, 55.56, 67.99, 112.28, 118.90, 119.78, 120.45, 126.77, 128.30, 135.81, 142.64, 143.25, 151.57, 156 (27) . [5, 10, porphyrinato]zinc(II) 17 (0.12 g, 0.13 mmol) was heated to reflux in THF (5 mL), ethanol (20 mL) and 2M NaOH (20 mL) for 5 hours. Filtration through a plug of silica gel eluting with CH 2 Cl 2 followed by evaporation of the solvent yielded a purple solid of 27 (0.10 g, 0.10 mmol, 82%): mp >310 o C; R f =0. 34.49, 120.22, 122.07, 128.14, 129.18, 131.08, 131.70, 134.06, 141.30, 147.98, 149.23, 149.87, 149.92 
Esterification of carboxylic acid porphyrins
Method A: DCC carbodiimide reagent approach.
To a solution of porphyrin, N,N-dicyclohexylcarbodiimide (DCC) and dimethylamino-pyridine (DMAP) in dry THF, a solution of 2-nitrobenzylalcohol in THF was added at room temperature. The mixture was heated to reflux for 18 hours and diluted with THF before being extracted with a solution of aq. NH 4 Cl. The organic solvent was washed with brine and dried over Na 2 SO 4 followed by evaporation of the solvent under reduced pressure and purification by column chromatography. 29, 24.19, 25.98, 30.47, 31.47, 35.16, 38.50, 49.49, 57.07, 62.05, 119.35, 120.82, 124.86, 126.23, 127.31, 134.04, 141.85, 144.44, 154 Hz, 1H, -NH), 7.79 (t, J= 7.6 Hz, 6H, phenyl-H), 7.97 (d, J= 7.6 Hz, 2H, phenyl-H), 8.24 (d, 4H, J=6.4 Hz, 8.28 (d, J=7.6 Hz, 2H, 8.82 (d, J=4.7 Hz, 2H, β-H), 8.92 (d, J=4.7Hz, 2H, 29.31, 30.51, 32.25, 57.07, 104.77, 118.46, 119.45, 124.77, 126.47, 127.40, 134.27, 135.93,141.20, 144.92, 154.08, 167.36, 170.77 27, 29.27, 31.49, 63.25, 117.84, 119.97, 124.79, 126.29, 127.67, 131.93, 133.49, 134.11, 141.57, 147.17, 147.28, 165.73 13 C NMR (100 MHz, CDCl 3 ): δ=29. 27, 32.21, 62.09, 124.57, 126.30, 127.37, 128.04, 129.51, 133.69, 134.12, 141.57, 167 .54 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 418 (5. 29.28, 31.30, 34.61, 63.23, 120.62, 121.22, 127.63, 128.66, 129.40, 134.25, 140.68, 148.32, 165.79 13 C NMR (100 MHz, CDCl 3 ): δ=24. 30, 25.96, 29.27, 31.30, 32.28, 34.61, 62.10, 117.43, 120.58, 121.18, 124.57, 128.04, 129.47, 133.69, 136.33, 140.67, 148.32, 154.08, 165 .73 ppm; UV-vis (CH 2 Cl 2 ): λ max (log ε)= 421 (5. 
5-(4-
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Method B: EDAC carbodiimide reagent approach.
To a solution of porphyrin (1 eq.), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDAC) (2 eq.) and dimethylaminopyridine, (DMAP) (2 eq.) in dry DCM, a solution of 2-nitrobenzylalcohol (4 eq.) in DCM were added at rt. The mixture was stirred at rt for 18 hours. Upon completion, the solution was diluted with DCM and extracted with a solution of aqueous NH 4 Cl. The mixture was washed with brine and dried over Na 2 SO 4 , followed by evaporation of the solvent to give the crude product and purification by column chromatography.
5-Hexyl-15-(4-(o-nitrobenzylcarboxy)phenyl)-10,20-diphenylporphyrin (36).
5-Hexyl-15-(4-carboxyphenyl)-10,20-diphenylporphyrin 18 (0.02 g, 0.03 mmol), EDAC (11.5 mg, 0.06 mmol), DMAP (7.31 mg, 0.06 mmol) and 2-nitrobenzylalcohol (18.6 mg, 0.12 mmol) were stirred for 18 h in DCM (10 mL) at rt according to method B (4.5.6). Purification on silica gel (nhexane/dichloromethane = 1:2, v/v) yielded 36 as a purple solid (13.0 8.24 (s, 1H, 8.29 (d, J=8.4 Hz, 2H, 8.45 (d, J=8.4 Hz, 2H, 8.72 (d, J=4.8 Hz, 2H, 8.79 (d, J=4.8 Hz, 2H, 8.89 (d, J=4.8 Hz, 2H, 9.48 (d, J=4.8 Hz, 2H, β-H);
13 C NMR (100 MHz, CDCl 3 ): δ=14. 14, 22.71, 29.38, 30.05, 30.28, 31.46, 31.95, 34.96, 63.68, 124.18, 124.40, 125.25, 126.66, 127.76, 127.97, 128.85, 128.93, 129.16, 130.93, 133.94, 134.74, 142.28, 151.22, 151.85 5.93 (s, 2H, 7.33 (d, J=8.1 Hz, 2H, 7.53 (t, J=7.7 Hz, 1H, 7.58 (t, J=8.0 Hz, 2H, 7.72 (t, J=7.36 Hz, 1H, 7.78 (t, J=7.7 Hz, 4H, 7.83 (d, J=7.7 Hz, 1H, 8.17 (d, J=8.1 Hz, 1H, 8.29 (d, J=8.4 Hz, 2H, 8.46 (d, J=8.4 Hz, 2H, 8.73 (d, J=4.8 Hz, 2H, 8.85 (d, J=4.8 Hz, 2H, 8.95 (d, J=4.8 Hz, 2H, 9.46 (d, J=4.8 Hz, 2H, β-H); 13 C NMR (100 MHz, CDCl 3 ): δ=14. 18, 22.74, 29.72, 30.33, 31.93, 35.62, 38.96, 55.55, 62.42, 63.69, 113.56, 117.52, 119.58, 120.50, 121.37, 124.96, 127.51, 128.41, 128.94, 129.81, 132.37, 133.94, 134.76, 136.82, 143.54, 147.50, 157.94, 166.24 ppm; Cl 2 ): λ max (log ε)= 419 (5.31), 514 (4.26), 550 (4.15), 578 (4.30), 654 (4.45) 15, porphyrinato]zinc(II) 27 (0.02 g, 0.02 mmol), EDAC (7.21 mg, 0.04 mmol), DMAP (4.59 mg, 0.04 4 Hz, 1H, 7.73 (t, J=8.4 Hz, 1H, 3H, 7.83 (d, J=8.0 Hz, 1H, 6H, 29.72, 31.77, 35.07, 63.60, 118.90, 120.87, 122.70, 125.21, 127.93, 128.90, 129.61, 132.43, 133.91, 134.57, 141.73, 148.61, 149.41, 150.41, 166 5.83 (s, 2H, 7.38 (t, J=8.4 Hz, 1H, 7.52 (t, J=7.7 Hz, 1H, 7.65 (d, J=7.7 Hz, 1H, 7.76 (m, 6H, 7.85 (t, J=7.7 Hz, 1H, 8.06 (d, J=8.4 Hz, 1H, 8.19 (d, J=6.2 Hz, 4H, 8.41 (d, J=7.7 Hz, 1H, 8.49 (d, J=7.7 Hz, 1H, 8.72 (d, J=4.8 Hz, 2H, 8.80 (d, J=4.8 Hz, 2H, 8.91 (t, J=2.2 Hz, 3H, 9.48 (d, J=4.8 Hz, 2H, β-H); 13 C NMR (100 MHz, CDCl 3 ): δ=14. 18, 22.74, 29.45, 29.74, 30.28, 31.93, 35.63, 38.95, 63.60, 117.46, 119.80, 121.24, 125.08, 126.67, 127.13, 127.75, 128.30, 129.19, 133.84, 134.90, 138.91, 142.30, 147.44, 166.17 5.85 (s, 4H, 7.42 (t, J=7.3 Hz, 2H, 7.57 (t, J=7.7 Hz, 2H, 7.69 (d, J=7.7 Hz, 2H, 7.79 (s, 2H, 7.87 (t, J=7.7 Hz, 2H, 8.08 (d, J=9.6 Hz, 6H, 8.44 (d, J=8.1 Hz, 2H, 8.51 (d, J=8.51 Hz, 2H, 8.77 (s, 2H, 8.78 (s, 2H, 8.90 (d, J=4.76 Hz, 4H, β-H), 8.94 (s, 2H, β-H);
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13 C NMR (100 MHz, CDCl 3 ): δ=27. 85, 29.71, 31.73, 35.07, 36.21, 52.29, 59.42, 63.64, 118.38, 121.16, 122.00, 125.12, 126.55, 128.39, 129.59, 132.28, 133.85, 137.62, 138.83, 140.91, 142.92, 147.53, 148.86, 151.63, 166.17, 170.95 27, 29.27, 29.81, 31.43, 35.07, 38.38, 62.09, 62.89, 120.33, 122.62, 124.56, 126.29, 127.45, 128.04, 128.70, 129.50, 133.97, 136.32, 141.65, 146.65 22.70, 28.22, 31.89, 35.50, 38.88, 55.54, 62.59, 110.58, 117.86, 120.43, 126.31, 128.86, 134.15, 143.43, 144.59, 147.96, 165.63, 169 20, 23.91, 29.43, 30.05, 32.76, 34.88, 37.11, 121.01, 128.70, 129.60, 130.04, 130.68, 133.80, 139.99, 147.99, 148.64, 148.82, 165.90 (3,5-di-tert-butylphenyl) porphyrin 29 (0.08 g, 0.08 mmol), EDAC (30.8 mg, 0.16 mmol) , DMAP (19.6 mg, 0.16 mmol) and 5-((acetoglucose)-2-nitrophenyl)methanol (0.16 g, 0.32 mmol) were stirred for 18 h in DCM (15 mL). The solution was diluted with DCM and extracted with a solution of aqueous NH 4 Cl. The mixture was washed with brine and dried over Na 2 SO 4 , followed by evaporation of the solvent to give the crude product. Purification on silica gel (n-hexane/ dichloromethane= 1 :1, v/v) 61.70, 63.74, 67.83, 70.94, 72.44, 98.08, 115.68, 116.81, 117.64, 121.10, 121.70, 122.05, 128.07, 128.61, 129.83, 134.83, 135.68, 141.14, 142.42, 148.25, 160.48, 169.23, 170.11, 170.43 27, 61.34, 67.57, 70.89, 92.61, 113.78, 114.57, 127.00, 139.81, 140.69, 161.16 29, 29.28, 29.83, 31.47, 35.17, 38.50, 58.64, 62.14, 62.70, 63.42, 67.88, 71.02, 93.03, 114.35, 115.67, 117.07, 119.40, 120.90, 126.23, 127.32, 127.71, 128.45, 134.04, 140.65, 141.83, 147.08, 159.69, 161.23, 165.68, 169.89 8.18 (d, J=6.4 Hz, 4H, 8.27 (d, J=8.2 Hz, 2H, 8.43 (d, J=8.2 Hz, 2H, 8.71 (d, J=5.3 Hz, 2H, 8.79 (d, J=4.7 Hz, 2H, 8.90 (d, J=5.2 Hz, 2H, 9.47 (d, J=4.7 Hz, 2H, β-H);
13 C NMR (100 MHz, CDCl 3 ): δ=14. 17, 22.74, 30.29, 31.94, 35.64, 38.95, 61.63, 66.98, 93.50, 114.94, 116.54, 117.59, 119.83, 121.33, 127.87, 128.92, 134.78, 142.30, 147.34, 167.24 Hexyl-15-(4'-(o-nitro-p-hydroxybenzyl-carboxy)-phenyl)-10,20-diphenylporphyrin (52) . A solution of [5-hexyl-15-(3-o-nitro-p-(methoxyethoxymethyl) benzyl carboxyphenyl)-10,20-diphenylporphyrinato]zinc(II) 51 (0.06 g, 0.06 mmol) in CH 2 Cl 2 (3.30 ml) was treated with trifluoroacetic acid (3.30 ml) , stirred at rt for 7 hours and concentrated. The solution was neutralized with aqueous-KOH and extracted with CH 2 Cl 2 . The organic phase was dried over Na 2 SO 4 , filtered and the solvent was removed under reduced pressure to yield the title compound 52 as a purple solid (34.8 mg, 0.03 20.78, 22.74, 29.40, 31.96, 35.65, 38.96, 62.58, 114.89, 121.09, 126.69, 127.79, 128.18, 128.39, 129.71, 134.77, 142.27, 148.73, 161.26, 169.54 
Irradiation Experiment
A 50 µM solution of 5, 10, 3', 4', 6 '-tetra-O-acetyl-β-D-galacto pyrano-side)benzyl)carboxy)phenyl)-porphyrin 44 in 2% water/ 98% acetone was placed in a quartz cuvette. Irradiation was performed using a photochemical chamber reactor (Rayonet Model RMR-600) with 350 ± 25 nm UV lamps. Aliquots of 20 µL were removed at different time intervals of irradiation and analyzed by analytical HPLC (detection UV: 350 nm) using a nucleosile 5u Si 100A (250 X 4.00 mm) column and eluting with a mixture of nHexane:Ethyl Acetate (50:50) at a flow rate of 1.5 ml/min.
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